Skip to content

Exploring the mechanism of "dampness" affecting the progression of diabetic nephropathy based on intestinal microecology and clinical translational study

Exploring the mechanism of "dampness" affecting the progression of diabetic nephropathy based on intestinal microecology and clinical translational study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083758
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic kidney disease

Interventions

Probiotics Group:Probiotics plus usual care
Chinese Herbal Medicine Group:Chinese Herbal Medicine Granules plus usual care
Probiotics Combined with Chinese Herbal Medicine Group:Probiotics plus Chinese Herbal Medicine Granules and usual care
Western medicine conventional treatment group:Conventional Western Medicine

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Age 18-80 years old; ? Meet the diagnostic criteria of diabetic nephropathy; ? Glomerular filtration rate eGFR in the range of 15-60 mL /min /1. 73 ? and fluctuation range = 30% in the 3 months before enrollment; ? Voluntary informed consent. Diagnostic criteria for diabetic nephropathy: meet the diagnostic criteria for diabetes mellitus established by the American Diabetes Association in 2020, i.e., a clear history of diabetes mellitus, as well as the existence of a causal relationship with changes in urinary albumin and renal function, and the exclusion of other primary and secondary glomerular and systemic diseases, and meet one of the following conditions: (1) Random urinary albumin- to-creatinine ratio (UACR) = 30 mg/g or urinary albumin excretion rate (UAER) = 30 mg/24h, and repeated examinations within 3 to 6 months of UACR or UAER, with 2 out of 3 times meeting or exceeding the threshold value; other interfering factors such as infection were excluded; (2) eGFR <60 mL/min/1.73m2 for no less than 3 months; (3) Renal puncture biopsy consistent with DKD pathologic changes.

Exclusion criteria

Exclusion criteria: ? taking antibiotic medication within 30 days or a probiotic product within 14 days; ? Immediate need for dialysis treatment; ? Being treated with hormones or immunosuppressants; ? Combination of active malignant tumors; ?Severe cardiac arrhythmia, severe heart failure, NYHA class III and above; ?. pregnant or lactating patients; ?. Those who are unable to cooperate, such as psychiatric patients; ?. patients who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Annual eGFR slope;

Secondary

MeasureTime frame
Urinary albumin creatinine ratio;Renal function set (serum creatinine, blood urea nitrogen, serum uric acid, serum albumin);HbA1c%;Blood lipids profile (triglycerides, cholesterol, high- and low-density lipoprotein cholesterol);The survival time of renal composite endpoint events;Urinary protein creatinine ratio;Score of dampness syndrome scale of Chinese medicine;

Countries

China

Contacts

Public ContactLei Zhang

Guangdong Provincial Hospital of Chinese Medicine

zhanglei@gzucm.edu.cn+86 136 0006 1616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026